10 Low Risk High Reward Stocks Set to Triple by 2030
The market is getting tough these days with increasing interest rates, tense world politics, and inconsistent economic conditions, and investors are constantly looking for opportunities.
Atyr Pharma Inc (ATYR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Dorset Management David M. Knott | 223,407 | $674,689 | -28% | 0.32% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 55,600 | $167,912 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 3,750 | 9,750 | 2025-03-17 | Filing | ||
| $1.93 | 52,300 | 413,023 | 2024-07-24 | Filing | ||
| $1.82 | 6,648 | 360,723 | 2024-07-23 | Filing | ||
| $1.74 | 41,052 | 354,075 | 2024-07-22 | Filing | ||
| $1.86 | 5,000 | 22,267 | 2024-06-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.78 | 1,254 | 31,763 | 2025-02-04 | Filing | ||
| $3.78 | 899 | 26,555 | 2025-02-04 | Filing | ||
| $1.69 | 1,590 | Officer | 20,821 | 2024-02-06 | Filing | |
| $2.36 | 1,566 | Officer | 15,460 | 2023-02-06 | Filing | |
| $4.34 | 2,500 | Director | 108,083 | 2021-05-21 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,666,600 | $44,293,132 | 0.1% | |
| 2. | 12,893,529 | $38,938,458 | 0% | |
| 3. | 4,006,735 | $12,100,339 | 0% | |
| 4. | 1,593,981 | $4,813,823 | 0% | |
| 5. | 382,317 | $1,154,598 | 0% |
News See All
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2024 Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Billionaire Hedge Funds
